pembrolizumab,telomelysin
merck,oncolys
['thank you', 'gi ', 'solid tumor']
our phase 1 /1b study of obp-301 in combination with pembolizumab in patients with advanced solid tumors (epoc1505) presented this morning at #aacr2023. thank you dr #takashikojima at the department of gi oncology, #ncche, japan 
Oncolys USA is a subsidiary of Oncolys Biopharma Inc, a clinical stage biotechnology developing virus driven immunotherapy for cancer. Talia Biran, President